ATE306264T1 - Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen- gonadenachse - Google Patents
Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen- gonadenachseInfo
- Publication number
- ATE306264T1 ATE306264T1 AT99967223T AT99967223T ATE306264T1 AT E306264 T1 ATE306264 T1 AT E306264T1 AT 99967223 T AT99967223 T AT 99967223T AT 99967223 T AT99967223 T AT 99967223T AT E306264 T1 ATE306264 T1 AT E306264T1
- Authority
- AT
- Austria
- Prior art keywords
- acetylcholinesterase inhibitors
- pitophysis
- hypothalamus
- modulate
- gonad axis
- Prior art date
Links
- 239000000544 cholinesterase inhibitor Substances 0.000 title abstract 3
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 abstract 2
- IYVSXSLYJLAZAT-NOLJZWGESA-N lycoramine Natural products CN1CC[C@@]23CC[C@H](O)C[C@@H]2Oc4cccc(C1)c34 IYVSXSLYJLAZAT-NOLJZWGESA-N 0.000 abstract 2
- GJRMHIXYLGOZSE-JDFRZJQESA-N 1,2-Dihydrogalanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)CC2 GJRMHIXYLGOZSE-JDFRZJQESA-N 0.000 abstract 1
- HPOIPOPJGBKXIR-UHFFFAOYSA-N 3,6-dimethoxy-10-methyl-galantham-1-ene Natural products O1C(C(=CC=2)OC)=C3C=2CN(C)CCC23C1CC(OC)C=C2 HPOIPOPJGBKXIR-UHFFFAOYSA-N 0.000 abstract 1
- LPCKPBWOSNVCEL-UHFFFAOYSA-N Chlidanthine Natural products O1C(C(=CC=2)O)=C3C=2CN(C)CCC23C1CC(OC)C=C2 LPCKPBWOSNVCEL-UHFFFAOYSA-N 0.000 abstract 1
- XSVMFMHYUFZWBK-NSHDSACASA-N Rivastigmine Chemical compound CCN(C)C(=O)OC1=CC=CC([C@H](C)N(C)C)=C1 XSVMFMHYUFZWBK-NSHDSACASA-N 0.000 abstract 1
- 206010059594 Secondary hypogonadism Diseases 0.000 abstract 1
- 206010003883 azoospermia Diseases 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 229960003980 galantamine Drugs 0.000 abstract 1
- BGLNUNCBNALFOZ-WMLDXEAASA-N galanthamine Natural products COc1ccc2CCCC[C@@]34C=CCC[C@@H]3Oc1c24 BGLNUNCBNALFOZ-WMLDXEAASA-N 0.000 abstract 1
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 abstract 1
- 230000004185 hypothalamic-pituitary-gonadal axis Effects 0.000 abstract 1
- 208000000509 infertility Diseases 0.000 abstract 1
- 231100000535 infertility Toxicity 0.000 abstract 1
- 230000036512 infertility Effects 0.000 abstract 1
- 231100000545 luteal phase defect Toxicity 0.000 abstract 1
- 208000008634 oligospermia Diseases 0.000 abstract 1
- 230000016087 ovulation Effects 0.000 abstract 1
- 229960004136 rivastigmine Drugs 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11191398P | 1998-12-11 | 1998-12-11 | |
| PCT/US1999/028972 WO2000033840A1 (en) | 1998-12-11 | 1999-12-08 | Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE306264T1 true ATE306264T1 (de) | 2005-10-15 |
Family
ID=22341099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99967223T ATE306264T1 (de) | 1998-12-11 | 1999-12-08 | Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen- gonadenachse |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1137414B1 (de) |
| JP (1) | JP2002531502A (de) |
| AT (1) | ATE306264T1 (de) |
| AU (1) | AU2354400A (de) |
| CA (1) | CA2354035A1 (de) |
| DE (1) | DE69927705T2 (de) |
| WO (1) | WO2000033840A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1777222A1 (de) * | 2005-09-22 | 2007-04-25 | Galantos Pharma GmbH | Cholinesterase Inhibitoren mit erhöter Blut Hirn Schranke Permeabilität zur Behandlung von kognitiven Störungen |
| US20090253654A1 (en) | 2005-09-22 | 2009-10-08 | Galantos Pharma Gmbh | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| US8278345B2 (en) | 2006-11-09 | 2012-10-02 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| JP5523107B2 (ja) | 2006-11-30 | 2014-06-18 | プロビオドルグ エージー | グルタミニルシクラーゼの新規阻害剤 |
| EP2481408A3 (de) | 2007-03-01 | 2013-01-09 | Probiodrug AG | Neue Verwendung von Inhibitoren der Glutaminyl Cyclase |
| WO2008128985A1 (en) | 2007-04-18 | 2008-10-30 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
| US20110212928A1 (en) | 2010-02-09 | 2011-09-01 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| JP6026284B2 (ja) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | グルタミニルシクラーゼの阻害剤 |
| US8269019B2 (en) | 2010-03-10 | 2012-09-18 | Probiodrug Ag | Inhibitors |
| WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
| ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
| WO2014078568A1 (en) | 2012-11-14 | 2014-05-22 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| EP2968220B1 (de) | 2013-03-15 | 2021-05-05 | Agenebio, Inc. | Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen |
| WO2014144663A1 (en) | 2013-03-15 | 2014-09-18 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| NZ738682A (en) | 2015-05-22 | 2022-01-28 | Agenebio Inc | Extended release pharmaceutical compositions of levetiracetam |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
| CN112121049B (zh) * | 2020-08-28 | 2022-02-01 | 嘉兴市第一医院 | 顺式阿曲库铵在制备治疗男性性腺功能减退症的药物中的应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL195004C (nl) * | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
-
1999
- 1999-12-08 AT AT99967223T patent/ATE306264T1/de not_active IP Right Cessation
- 1999-12-08 CA CA002354035A patent/CA2354035A1/en not_active Abandoned
- 1999-12-08 AU AU23544/00A patent/AU2354400A/en not_active Abandoned
- 1999-12-08 WO PCT/US1999/028972 patent/WO2000033840A1/en not_active Ceased
- 1999-12-08 JP JP2000586332A patent/JP2002531502A/ja active Pending
- 1999-12-08 EP EP99967223A patent/EP1137414B1/de not_active Expired - Lifetime
- 1999-12-08 DE DE69927705T patent/DE69927705T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1137414A4 (de) | 2002-07-31 |
| DE69927705D1 (de) | 2006-02-23 |
| EP1137414A1 (de) | 2001-10-04 |
| AU2354400A (en) | 2000-06-26 |
| JP2002531502A (ja) | 2002-09-24 |
| DE69927705T2 (de) | 2006-07-20 |
| WO2000033840A1 (en) | 2000-06-15 |
| EP1137414B1 (de) | 2005-10-12 |
| CA2354035A1 (en) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69927705D1 (de) | Verwendung von acetylcholinesterase inhibitoren zur modulierung der hypothalamus-hypophysen-gonadenachse | |
| IL125590A0 (en) | Peptide immunogens | |
| ATE298248T1 (de) | T-zell inhibierende rezeptorzusammensetzungen sowie deren verwendung | |
| EP0335637A3 (de) | Nervenwachstumsfaktor-Peptide | |
| MX9801093A (es) | Inhibidores de la proteinasa c para el tratamiento de enfermedades relacionadas con la sobreproduccion de colagena. | |
| DK0918774T3 (da) | Androgenreceptormodulatorforbindelser og fremgangsmåder | |
| DE69715861D1 (de) | Verwendung von pyridyl-alkan-,pyridiyl alkan- und/oder pyridyl-säuren amiden zur behandlung von tumoren oder für immunsuppression | |
| WO1999007736A3 (en) | Lipoprotein-regulating medicaments | |
| MY138258A (en) | Growth hormone secretagogues | |
| NO990086D0 (no) | Avkortete, oppl÷selige tumornekrosefaktorreseptorer av type I og type II | |
| ATE313802T1 (de) | Bestimmung von adrenomedullin-bindenden proteinen | |
| DE69813898D1 (de) | Substituierte porphyrinen | |
| TW200640944A (en) | VGF polypeptides and methods of treating VGF-related disorders | |
| ATE271880T1 (de) | Methoden zur behandlung von diabetes | |
| EA200000519A1 (ru) | 2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ | |
| DE69943222D1 (de) | Menschliche ubiqutin ligase e3. verwendung für die modulation von nf-kappa b | |
| WO2002054066A3 (en) | Non-apoptotic forms of cell death and methods of modulation | |
| MXPA02000680A (es) | Polipeptidos vgf y metodos para tratar desordenes relacionados con vgf. | |
| WO2002078606A3 (en) | Thrombospondin-2 and uses thereof | |
| AU7216498A (en) | Inhibitors of the urokinase receptor | |
| EP1073683A4 (de) | G-csf-rezeptoragonist-antikörper und methode zu ihrer isolierung mittels durchmusterung | |
| DE69718146D1 (de) | At1 rezeptor antagonist zur anregung von apoptosis | |
| EA199800889A1 (ru) | Способ предупреждения и/или лечения сердечной недостаточности и дисфункции желудочков антагонистами эндотелина, фармацевтическая композиция | |
| ATE362768T1 (de) | Prb2/p130 peptidinhibitoren der cdk2 kinaseaktivität | |
| CA2310748A1 (en) | Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |